Informations sur le produit
- (1R,2R)-(-)-1-Amino-2-benzyloxycyclohexane
- (1R,2R)-2-(Phenylmethoxy)cyclohexanamine
- (1R,2R)-2-(benzyloxy)cyclohexanamine
- (1R,2R)-2-phenylmethoxycyclohexan-1-amine
- (1R-trans)-(-)-2-(Phenylmethoxy)cyclohexanamine
- (1R-trans)-2-(Phenylmethoxy)cyclohexaneamine
- Cyclohexanamine, 2-(phenylmethoxy)-, (1R,2R)-
- [(1R,2R)-2-(Benzyloxy)cyclohex-1-yl]amine
- [(1R,2R)-2-(Benzyloxy)cyclohexyl]amine
(1R,2R)-(-)-2-Benzyloxycyclohexylamine is a potent and selective κ opioid receptor antagonist. It has a high affinity for the κ opioid receptor, which is thought to be due to structural factors that are not shared with other classes of opioids. This drug has been shown to block the effects of κ opioid agonists in animals, suggesting that it may also have therapeutic potential for treatment of opioid overdose. The structural factors responsible for (1R,2R)-(-)-2-benzyloxycyclohexylamine's binding affinity at the κ opioid receptor have been elucidated using molecular modeling techniques. However, its selectivity for this receptor over the μ and δ receptors remains unclear.